glioma
NIH Launches New Childhood Cancer Genomics Program
Pediatric and young adult patients treated at facilities affiliated with the NCI-sponsored Children's Oncology Group gain new, broad access to tumor molecular profiling.
Thermo Fisher Scientific, Agios Pharmaceuticals to Codevelop Glioma Companion Diagnostic
Thermo will develop a test using its Oncomine Precision Assay to identify IDH1- and IDH2-positive low-grade glioma patients for treatment with Agios' vorasidenib.
The researchers believe using cerebral spinal fluid will enable them to identify brain tumors with a higher sensitivity than with blood samples.
The researchers aim to offer the half-hour diagnostic assay for use during neurosurgery to help clinicians pursue the best treatment for patients with gliomas.
The researchers said that their deep-learning interpreter of outcomes for patients with gliomas could be more accurate and objective than pathologists.